Abstract:This paper aimed to improve in vitro dissolution/solubility as well as inhibit intestinal metabolism and thus enhance oral bioavailability for a BDDCS class II drug by constructing surfactant-based amorphous solid dispersions using resveratrol (RES) as a model drug. After preliminary screening of polymers and surfactants, and subsequent prescription optimization, two optimized spray-drying RES-polymer-surfactant ASDs were obtained and exhibited a significant increase in solubility of RES by 2.69-3.45-fold compared to crystalline RES, and by 1.13-1.56-fold compared to corresponding RES-polymer ASDs, maintaining a higher concentration in the dissolution process. A metabolism study using everted sacs showed that two optimized ASDs reduced the concentration ratio of RES-G to RES to 51.66%-52.05% of crystalline RES on the serosal side of the rat everted intestinal sac at 2 h. Consequently, these two RES-polymer-surfactant ASDs achieved significantly higher exposure of RES in the plasma with significant enhancements in Cmax (2.33-2.35-fold higher than crystalline RES, and 1.72-2.04-fold higher than corresponding RES-polymer ASDs), and in AUC 0-∞ (3.51-3.56-fold higher than crystalline RES, and 1.38-1.41-fold higher than corresponding RES-polymer ASDs). These advantages of the RES-polymer-surfactant ASDs in oral absorption of RES were attributed to solubilization by ASDs and metabolic inhibition by UGT inhibitors. The introduction of surfactants including EL and Lab to ASDs plays an important role in inhibiting glucuronidation and further improving solubility. This study demonstrated that such surfactant-based amorphous solid dispersions may serve as a new approach to increase the oral absorption of BDDCS class II drugs.

Development Of Phospholipid Complex Loaded Self-Microemulsifying Drug Delivery System To Improve The Oral Bioavailability Of Resveratrol

Oral Bioavailability and Lymphatic Transport of Pueraria Flavone-Loaded Self-Emulsifying Drug-Delivery Systems Containing Sodium Taurocholate in Rats.

Enhanced Oral Bioavailability of Oligomeric Proanthocyanidins by a Self-Double-emulsifying Drug Delivery System

Optimization of a Self-Microemulsifying Drug Delivery System for Oral Administration of the Lipophilic Drug, Resveratrol: Enhanced Intestinal Permeability in Rat

A self-microemulsifying drug delivery system to overcome intestinal resveratrol toxicity and presystemic metabolism

Resveratrol Loaded Self-Microemulsifying Drug Delivery System (SMEDDS): Development and Optimization

Preparation and Characterisation of A Soy Lecithin-Based Self-Microemulsifying Drug Delivery System of Resveratrol

Preparation and in Vitro/in Vivo Evaluation of Resveratrol-Loaded Carboxymethyl Chitosan Nanoparticles

Development of a Resveratrol–zein–dopamine–lecithin Delivery System with Enhanced Stability and Mucus Permeation

Self-microemulsifying Drug Delivery System for Improved Oral Bioavailability of Oleanolic Acid: Design and Evaluation.

Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation

Optimization and bioavailability evaluation of self-microemulsifying drug delivery system of the daidzein–nicotinamide complex

Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.

Self-microemulsifying drug-delivery system for improved oral bioavailability of probucol: preparation and evaluation.

Enhanced Oral Bioavailability of Daidzein by Self-Microemulsifying Drug Delivery System

A New Strategy for Enhancing the Oral Bioavailability of Drugs with Poor Water-Solubility and Low Liposolubility Based on Phospholipid Complex and Supersaturated SEDDS

Use of surfactant-based amorphous solid dispersions for BDDCS class II drugs to enhance oral bioavailability: A case report of resveratrol

Mechanisms Of Oral Absorption Improvement For Insoluble Drugs By The Combination Of Phospholipid Complex And Snedds

A novel sodium caseinate lipid-based auto-emulsifying delivery system to increase resveratrol intestinal permeation: Characterization and in vitro assessment

Improved Oral Bioavailability and Hypolipidemic Effect of Syringic Acid via a Self-microemulsifying Drug Delivery System

Integration of Phospholipid-Drug Complex into Self-Nanoemulsifying Drug Delivery System to Facilitate Oral Delivery of Paclitaxel